Hong Kong Logistics Stock News

SEHK:1167
SEHK:1167Biotechs

Jacobio Pharmaceuticals Group (SEHK:1167) Loss Narrows To C¥58.9m Challenging Bearish Narratives

Jacobio Pharmaceuticals Group (SEHK:1167) opened FY 2025 with first half revenue of C¥45.7 million and a basic EPS loss of C¥0.08, while trailing 12 month figures show revenue of C¥53.5 million and a basic EPS loss of about C¥0.19, underlining that the business is still in loss making territory on a full year view. The company has seen revenue move from C¥155.7 million with basic EPS of C¥0.02 in 2H 2024 to C¥45.7 million with basic EPS of C¥0.08 loss in 1H 2025, against a trailing 12 month...
SEHK:778
SEHK:778Retail REITs

Fortune REIT SEHK 778 Half Year Revenue HK$854 Million Tests Recovery Narratives

Latest FY 2025 Earnings Snapshot Fortune Real Estate Investment Trust (SEHK:778) has posted its FY 2025 first half numbers with revenue of HK$854.5 million and basic EPS of HK$0.32 loss per share, setting a cautious tone for the latest results. Over the recent reporting periods, revenue has moved from HK$871.8 million in 1H 2024 to HK$874.5 million in 2H 2024 and now HK$854.5 million in 1H 2025. Over the same intervals, basic EPS shifted from a HK$0.02 loss to a HK$0.24 loss and then a...
SEHK:1970
SEHK:1970Entertainment

IMAX China Holding (SEHK:1970) Margin Expansion Reinforces Bullish Narratives

IMAX China Holding FY 2025 Earnings Snapshot IMAX China Holding (SEHK:1970) has wrapped up FY 2025 with second half revenue of US$44.5 million and basic EPS of US$0.04, alongside trailing 12 month EPS of US$0.11 on revenue of US$102.3 million that reflects a 69.6% earnings increase over the past year. The company has seen revenue move from US$37.1 million and EPS of US$0.03 in the second half of 2024 to US$44.5 million and EPS of US$0.04 in the second half of 2025, while trailing net income...
SEHK:1211
SEHK:1211Auto

BYD’s Ultra-Fast FLASH Charging And New Blade Battery Might Change The Case For Investing In BYD (SEHK:1211)

In March 2026, BYD Company Limited reported that its February production and sales volumes were lower than a year earlier, while also unveiling its FLASH Charging technology and second-generation Blade Battery with faster charging and improved energy density. These battery and charging innovations, including very high-power FLASH Charging and an expanded station rollout plan, signal BYD’s push to reshape how quickly and efficiently electric vehicles can be recharged in China and...
SEHK:522
SEHK:522Semiconductor

Assessing ASMPT (SEHK:522) Valuation After Strong 2026 Guidance Dividends Boost And NEXX Divestment

ASMPT (SEHK:522) has packed several updates into its latest announcement, combining first quarter 2026 revenue guidance, higher proposed dividends, and the planned divestment of NEXX into a single reference point for investors. See our latest analysis for ASMPT. Those updates are landing after a strong run in the shares, with ASMPT’s 90 day share price return of 45.27% and 1 year total shareholder return of 94.12% pointing to momentum building as investors reassess growth prospects and...
SEHK:2096
SEHK:2096Pharmaceuticals

A Look At Simcere Pharmaceutical Group (SEHK:2096) Valuation As 2025 Growth Guidance Draws Investor Focus

Guidance-driven spotlight on Simcere Pharmaceutical Group Simcere Pharmaceutical Group (SEHK:2096) has issued consolidated guidance for 2025, indicating expected revenue of RMB 7,700 million to RMB 7,800 million and profit attributable to equity shareholders of RMB 1,300 million to RMB 1,400 million. See our latest analysis for Simcere Pharmaceutical Group. The guidance update comes after a mixed share price run, with a 7 day share price return of 3.55% and a 90 day share price return decline...
SEHK:460
SEHK:460Pharmaceuticals

Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Bireociclib’s New First Line Breast Cancer Approval

Sihuan Pharmaceutical Holdings Group (SEHK:460) drew investor attention after China approved a new first-line indication for its Bireociclib Tablets in HR+/HER2- advanced breast cancer, expanding coverage across all treatment lines. See our latest analysis for Sihuan Pharmaceutical Holdings Group. At a share price of HK$1.49, the stock has seen a 6.43% 7 day share price return and a 16.41% 90 day share price return. The 1 year total shareholder return of 150.06% points to strong momentum,...
SEHK:2
SEHK:2Electric Utilities

Assessing CLP Holdings (SEHK:2) Valuation After Weaker 2025 Results And New Fourth Interim Dividend

CLP Holdings (SEHK:2) is back in focus after releasing its full year 2025 results. The company reported lower sales and net income year on year and declared a fourth interim dividend of HK$1.31 per share. See our latest analysis for CLP Holdings. At a share price of HK$74.75, CLP Holdings has delivered a 10.82% 90 day share price return and a 21.83% 1 year total shareholder return, suggesting momentum has been rebuilding recently despite softer reported earnings. If this earnings and dividend...
SEHK:6181
SEHK:6181Luxury

Assessing Laopu Gold (SEHK:6181) Valuation After Its Recent Addition To The Hang Seng Index

Laopu Gold (SEHK:6181) has been added to the Hang Seng Index, an event that can increase attention from index funds and benchmarked investors as they reassess exposure to Hong Kong listed jewelry names. See our latest analysis for Laopu Gold. The index inclusion comes after a period where Laopu Gold’s 90 day share price return of 2.65% and year to date share price return of 2.73% contrast with a 1 year total shareholder return decline of 5.48%, suggesting short term momentum has picked up...
SEHK:960
SEHK:960Real Estate

Longfor Group Holdings (SEHK:960) Valuation After 2025 Earnings Guidance Flags Core Net Loss And Sector Weakness

Longfor Group Holdings (SEHK:960) has drawn fresh attention after issuing unaudited 2025 earnings guidance that indicates a sharp drop in profit and a core net loss, despite continued positive operating cash flow. See our latest analysis for Longfor Group Holdings. The earnings guidance and recent sales update come after a choppy period for the share price, with a 1-month share price return showing a 10.81% decline and a 1-year total shareholder return showing a 14.61% decline, pointing to...
SEHK:2233
SEHK:2233Basic Materials

A Look At West China Cement (SEHK:2233) Valuation After Profit Guidance Forecasting 33% To 43% Growth

West China Cement (SEHK:2233) has issued fresh guidance, telling investors it expects profit attributable to shareholders for 2025 to be in the range of CN¥832.8 million to CN¥895.5 million, an increase of about 33% to 43% year on year. See our latest analysis for West China Cement. The guidance has arrived after a sharp pullback in the share price, with West China Cement closing at HK$2.21 following a 1 day share price return of 4.25%, yet posting a 30 day share price return of 23.79% and a...
SEHK:1138
SEHK:1138Oil and Gas

A Look At COSCO SHIPPING Energy Transportation (SEHK:1138) Valuation As VLCC Rate Optimism Faces Fresh Scrutiny

Why recent VLCC rate concerns matter for COSCO SHIPPING Energy Transportation (SEHK:1138) Recent commentary questioning how long elevated Very Large Crude Carrier freight rates can last has put fresh attention on COSCO SHIPPING Energy Transportation, where a strong rally and a higher P/B ratio are raising valuation questions. See our latest analysis for COSCO SHIPPING Energy Transportation. At a share price of HK$18.05, COSCO SHIPPING Energy Transportation has seen strong momentum, with a 30...
SEHK:700
SEHK:700Interactive Media and Services

Tencent Weighs AI Gaming Push And Media Investment Against Valuation Gap

Tencent Holdings (SEHK:700) has introduced a suite of AI powered game development tools at the 2026 Game Developers Conference, targeting animation, testing, anti cheat, and automated content creation. The company is also involved as a potential financial backer in the proposed US$110b Paramount Skydance acquisition of Warner Bros. Discovery, with an emphasis on a passive investment role. These moves highlight Tencent's push to deepen AI use in its core gaming operations while seeking...
SEHK:215
SEHK:215Wireless Telecom

Hutchison Telecom (SEHK:215) Thin H1 Profit Tests Optimistic Turnaround Narratives

Hutchison Telecommunications Hong Kong Holdings (SEHK:215) posts modest FY 2025 first half profit Hutchison Telecommunications Hong Kong Holdings (SEHK:215) has released its FY 2025 first half results with revenue of HK$2,216 million and net income (excluding extra items) of HK$6 million, equal to basic EPS of HK$0.001245. The company’s half year revenue moved from HK$2,058 million in 2024 H1 to HK$2,724 million in 2024 H2 and HK$2,216 million in 2025 H1. Basic EPS shifted from a loss of...
SEHK:2319
SEHK:2319Food

Does China Mengniu (SEHK:2319) Impairment Shift Reveal a New Balance Between Efficiency and Shareholder Cash?

China Mengniu Dairy Company Limited was recently removed from the Hang Seng China Enterprises Index and announced plans to book RMB 2.20–2.40 billion in impairment provisions on idle production facilities and certain financial and contract assets. At the same time, the company has scheduled a March 25, 2026 board meeting to approve its 2025 annual results and consider a final dividend, underscoring a balance between addressing asset quality issues and potential cash returns to...
SEHK:3393
SEHK:3393Electronic

Assessing Wasion Holdings (SEHK:3393) Valuation After Upgraded 2025 Profit Guidance

Wasion Holdings (SEHK:3393) issued new earnings guidance for 2025, projecting consolidated net profit of CN¥1,000 million to CN¥1,060 million, compared with about CN¥705.61 million in 2024, citing higher sales and tighter cost controls. See our latest analysis for Wasion Holdings. The new guidance comes after a powerful run in the shares, with a 90 day share price return of 78.42% and a 1 year total shareholder return that is more than triple the initial investment. This suggests that...
SEHK:3320
SEHK:3320Pharmaceuticals

A Look At China Resources Pharmaceutical Group (SEHK:3320) Valuation As Board Sets Date For Results And Dividend Decision

China Resources Pharmaceutical Group (SEHK:3320) has scheduled a board meeting for 24 March 2026 to approve its audited 2025 results and consider a final dividend, a key date for investors tracking income and performance. See our latest analysis for China Resources Pharmaceutical Group. At a share price of HK$4.55, China Resources Pharmaceutical Group has seen modest short term momentum, with a 1-day share price return of 1.34% and a year to date share price return of 0.89%. However, the...
SEHK:3330
SEHK:3330Metals and Mining

Lingbao Gold Group’s Valuation After Hang Seng Index And Stock Connect Inclusions

Lingbao Gold Group (SEHK:3330) is back on investors’ radar after its H shares were confirmed for inclusion in the Hang Seng Composite Index, as well as the Shanghai Hong Kong and Shenzhen Hong Kong Stock Connect schemes. See our latest analysis for Lingbao Gold Group. The latest index and Stock Connect confirmations have arrived after a strong period for the shares, with the HK$27.74 price sitting alongside a 30 day share price return of 29.51% and a 1 year total shareholder return of...
SEHK:981
SEHK:981Semiconductor

Assessing Semiconductor Manufacturing International (SEHK:981) Valuation After Recent Share Price Weakness

What recent performance hints at for Semiconductor Manufacturing International Semiconductor Manufacturing International (SEHK:981) has seen its share price move lower recently, with a 1.5% decline over the past day and deeper falls over the past week and month. Against that price pressure, the company reports annual revenue of $9,045.37m and net income of $619.867m, alongside annual revenue growth of 12.3% and net income growth of 23.7%. See our latest analysis for Semiconductor...
SEHK:6869
SEHK:6869Communications

Assessing Yangtze Optical Fibre And Cable (SEHK:6869) Valuation After MWC 2026 AI Infrastructure Showcase

Yangtze Optical Fibre And Cable Limited (SEHK:6869) is back in focus after its Mobile World Congress 2026 showcase, where it highlighted all optical solutions built around AI computing, smart mobility, and proprietary hollow core fibre. See our latest analysis for Yangtze Optical Fibre And Cable Limited. The recent MWC announcements land at a time when Yangtze Optical Fibre And Cable Limited’s share price has climbed to HK$142.2, with a 30 day share price return of 56.61% and a 90 day gain...
SEHK:6963
SEHK:6963Insurance

A Look At Sunshine Insurance Group (SEHK:6963) Valuation As Board Reviews Results And Proposed Final Dividend

Sunshine Insurance Group (SEHK:6963) has called a March 16, 2026 board meeting to review audited 2025 results and consider a final dividend. This will be a key moment for investors watching earnings quality and capital returns. See our latest analysis for Sunshine Insurance Group. The upcoming results and dividend decision come after a softer patch in the share price, with a 30 day share price return of a 13.01% decline and a year to date share price return of an 8.84% decline. However, a 1...
SEHK:1070
SEHK:1070Consumer Durables

TCL Electronics Holdings (SEHK:1070) Valuation Check After MWC 2026 Product And Technology Launches

TCL Electronics Holdings (SEHK:1070) has attracted fresh attention after using Mobile World Congress 2026 to showcase its NXTPAPER 70 Pro smartphone, new NXTPAPER AMOLED display tech, connectivity devices, CrystalClip earbuds and the conceptual Tbot kids companion. See our latest analysis for TCL Electronics Holdings. Despite the fresh product buzz from MWC 2026, TCL Electronics Holdings’ recent share price has been choppy, with a 1-day share price return of a 3.73% decline and a 30-day share...
SEHK:220
SEHK:220Food

Assessing Uni-President China Holdings (SEHK:220) Valuation After 2025 Annual Results Update

Uni-President China Holdings (SEHK:220) has released its 2025 full-year results, giving investors fresh detail on sales of CNY 31,714.31 million and net income of CNY 2,050.23 million. See our latest analysis for Uni-President China Holdings. The results release comes after a period where momentum has started to pick up, with a 1-day share price return of 3.86% and a 30-day share price return of 7.19%. Over three years, the total shareholder return of 22.04% contrasts with a 1-year total...
SEHK:6979
SEHK:6979Beverage

Assessing ZJLD Group (SEHK:6979) Valuation After Sharp 2025 Earnings Guidance Cut

ZJLD Group (SEHK:6979) has issued unaudited earnings guidance for 2025, flagging revenue of around CN¥3.55b to CN¥3.70b and profit of CN¥0.52b to CN¥0.58b, both sharply lower than 2024. See our latest analysis for ZJLD Group. The earnings guidance lands after a strong run in the shares, with a 90 day share price return of 16% and a 1 year total shareholder return of 35.19%. This suggests momentum has been positive even as expectations for 2025 are reset. At the latest share price of HK$9.28,...